RNA interference: From model organisms towards therapy for neural and neuromuscular disorders

Human Molecular Genetics

Volumn 13, Issue REV. ISS. 2, 2004, Pages

  Buckingham, Steven D ^a   Esmaeili, Behrooz ^a   Wood, Matthew ^a   Sattelle, David B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMYLOID PROTEIN; DOUBLE STRANDED RNA; DOUBLECORTIN; DYSTROPHIN; EMERIN; HUNTINGTIN; MESSENGER RNA; NICOTINE; PARKIN;

ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; DEVELOPMENTAL DISORDER; DROSOPHILA MELANOGASTER; DRUG DEPENDENCE; DUCHENNE MUSCULAR DYSTROPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; EXPERIMENTAL MODEL; FRAGILE X SYNDROME; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC SCREENING; HUNTINGTON CHOREA; KENNEDY DISEASE; MOLECULAR MECHANICS; MOUSE; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; RNA SEQUENCE; SEQUENCE HOMOLOGY; SPINAL MUSCULAR ATROPHY; TRINUCLEOTIDE REPEAT;

ANIMALS; GENE THERAPY; HUMANS; NEURAL PATHWAYS; NEUROMUSCULAR DISEASES; RNA INTERFERENCE;

CAENORHABDITIS; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; MAMMALIA; MELANOGASTER;

EID: 5444234179     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh224     Document Type: Review

References (161)

1. Sijen, T., Fleenor, J., Simmer, F., Thijssen, K.L., Parrish, S., Timmons, L., Plasterk, R.H. and Fire, A. (2001) On the role of RNA amplification in dsRNA-triggered gene silencing. Cell, 107, 465-476.
2. Provost, P., Silverstein, R.A., Dishart, D., Walfridsson, J., Djupedal, I., Kniola, B., Wright, A., Samuelsson, B., Radmark, O. and Ekwall, K. (2002) Dicer is required for chromosome segregation and gene silencing in fission yeast cells. Proc. Natl Acad. Sci. USA, 99 16648-16653.
3. Volpe, T.A., Kidner, C., Hall, I.M., Teng, G., Grewal, S.I. and Martienssen, R.A. (2002) Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science, 297, 1833-1837.
4. Simmer, F., Tijsterman, M., Parrish, S., Koushika, S.P., Nonet, M.L., Fire, A., Ahringer, J. and Plasterk, R.H. (2002) Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr. Biol., 12, 1317-1319.
5. Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H. and Williams, B.R. (2003) Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol., 5, 834-839.
6. Kamath, R.S., Fraser, A.G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M. et al. (2003) Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature, 421, 231-237.
7. Fraser, A.G., Kamath, R.S., Zipperlen, P., Martinez-Campos, M., Sohrmann, M. and Ahringer, J. (2000) Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325-330.
8. Simmer, F., Moorman, C., Van Der Linden, A.M., Kuijk, E., Van Den Berghe, P.V., Kamath, R., Fraser, A.G., Ahringer, J. and Plasterk, R.H. (2003) Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol., 1, 77-84.
9. Vastenhouw, N.L., Fischer, S.E., Robert, V.J., Thijssen, K.L., Fraser, A.G., Kamath, R.S., Ahringer, J. and Plasterk, R.H. (2003) A genome-wide screen identifies 27 genes involved in transposon silencing in C. elegans. Curr. Biol., 13, 1311-1316.
10. Kamath, R.S. and Ahringer, J. (2003) Genome-wide RNAi screening in Caenorhabditis elegans. Methods, 30, 313-321.
11. Chamberlain, J.S. and Benian, G.M. (2000) Muscular dystrophy: the worm turns to genetic disease. Curr. Biol., 10, R795-7.
12. Culetto, E. and Sattelle, D.B. (2000) A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes. Hum. Mol. Genet., 9, 869-877.
13. Fortini, M.E. and Bonini, N.M. (2000) Modeling human neurodegenerative diseases in Drosophila: on a wing and a prayer. Trends Genet., 16, 161-167.
14. Link, C.D. (2001) Transgenic invertebrate models of age-associated neurodegenerative diseases. Mech. Ageing Dev., 122, 1639-1649.
15. Chan, H.Y. and Bonini, N.M. (2000) Drosophila models of human neurodegenerative disease. Cell Death Differ., 7, 1075-1080.
16. Ueda, R. (2001) RNAi: a new technology in the post-genomic sequencing era. J. Neurogenet., 15, 193-204.
17. Yin, J.Q. and Wan, Y. (2002) RNA-mediated gene regulation system: now and the future. Int. J. Mol. Med., 10, 355-365.
18. Paddison, P.J. and Hannon, G.J. (2003) siRNAs and shRNAs: skeleton keys to the human genome. Curr. Opin. Mol. Ther., 5, 217-224.
19. Arenz, C. and Schepers, U. (2003) RNA interference: from an ancient mechanism to a state of the art therapeutic application? Naturwissenschaften, 90, 345-359.
20. Cheng, J.C., Moore, T.B. and Sakamoto, K.M. (2003) RNA interference and human disease. Mol. Genet. Metab., 80, 121-128.
21. Zhang, J. and Hua, Z.C. (2004) Targeted gene silencing by small interfering RNA-based knock-down technology. Curr. Pharm. Biotechnol., 5, 1-7.
22. Amano, T., Yamasaki, S., Yagishita, N., Tsuchimochi, K., Shin, H., Kawahara, K., Aratani, S., Fujita, H., Zhang, L., Ikeda, R. et al. (2003) Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev., 17, 2436-2449.
23. Dave, R.S. and Pomerantz, R.J. (2003) RNA interference: on the road to an alternate therapeutic strategy! Rev. Med. Virol., 13, 373-385.
24. Bedford, J.S. and Liber, H.L. (2003) Applications of RNA interference for studies in DNA damage processing, genome stability, mutagenesis, and cancer. Semin. Cancer Biol., 13, 301-308.
25. Wilson, J.A. and Richardson, C.D. (2003) Induction of RNA interference using short interfering RNA expression vectors in cell culture and animal systems. Curr. Gpin. Mol. Ther., 5, 389-396.
26. Lavery, K.S. and King, T.H. (2003) Antisense and RNAi: powerful tools in drug target discovery and validation. Curr. Opin. Drug Discov. Devel., 6, 561-569.
27. Caplen, N.J. (2003) RNAi as a gene therapy approach. Expert Opin. Biol. Ther., 3, 575-586.
28. Schmid, A., Schindelholz, B. and Zinn, K. (2002) Combinatorial RNAi: a method for evaluating the functions of gene families in Drosophila. Trends Neurosci., 25, 71-74.
29. Wood, M.J., Trulzsch, B., Abdelgany, A. and Beeson, D. (2003) Therapeutic gene silencing in the nervous system. Hum. Mol. Genet., 12 (Spec. No. 2), R279-R284.
30. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
31. Tijsterman, M., Ketting, R.F. and Plasterk, R.H. (2002) The genetics of RNA silencing. Annu. Rev. Genet., 36, 489-519.
32. Winston, W.M., Molodowitch, C. and Hunter, C.P. (2002) Systemic RNAi in C. elegans requires the putative transmembrane protein SID-1. Science, 295, 2456-2459.
33. Feinberg, E.H. and Hunter, C.P. (2003) Transport of dsRNA into cells by the transmembrane protein SID-1. Science, 301, 1545-1547.
34. Nykanen, A., Haley, B. and Zamore, P.D. (2001) ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell, 107, 309-321.
35. Liu, Q., Rand, T.A., Kalidas, S., Du, F., Kim, H.E., Smith, D.P. and Wang, X. (2003) R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science, 301, 1921-1925.
36. Williams, R.W. and Rubin, G.M. (2002) ARGONAUTE1 is required for efficient RNA interference in Drosophila embryos. Proc. Natl Acad. Sci. USA, 99, 6889-6894.
37. Caudy, A.A., Ketting, R.F., Hammond, S.M., Denli, A.M., Bathoorn, A.M., Tops, B.B., Silva, J.M., Myers, M.M., Hannon, G.J. and Plasterk, R.H. (2003) A micrococcal nuclease homologue in RNAi effector complexes. Nature, 425, 411-414.
38. Harborth, J., Elbashir, S.M., Vandenburgh, K., Manninga, H., Scaringe, S.A., Weber, K. and Tuschl, T. (2003) Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucl. Acid Drug Dev. 13, 83-105.
39. Caplen, N.J., Fleenor, J., Fire, A. and Morgan, R.A. (2000) dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference. Gene, 252 95-105.
40. Silverstein, A.M. and Mumby, M.C. (2003) Analysis of protein phosphatase function in Drosophila cells using RNA interference. Methods Enzymol., 366, 361-372.
41. Elbashir, S.M., Lendeckel, W. and Tuschl, T. (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev., 15, 188-200.
42. Kalidas, S. and Smith, D.P. (2002) Novel genomic cDNA hybrids produce effective RNA interference in adult Drosophila. Neuron, 33, 177-184.
43. Kamath, R.S., Martinez-Campos, M., Zipperlen, P., Fraser, A.G. and Ahringer, J. (2001) Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol., 2, 20.
44. Tabara, H., Grishok, A. and Mello, C.C. (1998) RNAi in C. elegans: soaking in the genome sequence. Science, 282, 430-431.
45. Mariol, M.C. and Segalat, L. (2001) Muscular degeneration in the absence of dystrophin is a calcium-dependent process. Curr. Biol. 11, 1691-1694.
46. Kennedy, S., Wang, D. and Ruvkun, G. (2004) A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature, 427, 645-649.
47. Timmons, L., Tabara, H., Mello, C.C. and Fire, A.Z. (2003) Inducible systemic RNA silencing in Caenorhabditis elegans. Mol. Biol. Cell., 14, 2972-2983.
48. Poinat, P., De Arcangelis, A., Sookhareea, S., Zhu, X., Hedgecock, E.M., Labouesse, M. and Georges-Labouesse, E. (2002) A conserved interaction between beta1 integrin/PAT-3 and Nck-interacting kinase/MIG-15 that mediates commissural axon navigation in C. elegans. Curr. Biol., 12, 622-631.
49. Hutvagner, G. and Zamore, P.D. (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297, 2056-2060.
50. Gunsalus, K.C., Yueh, W.C., MacMenamin, P. and Piano, F. (2004) RNAiDB and PhenoBlast: web tools for genome-wide phenotypic mapping projects. Nucleic Acids Res., 32 (Database issue), D406-D410.
51. Link, C.D. (1995) Expression of human β-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl Acad. Sci. USA, 92 9368-9372.
52. Satyal, S.H., Schmidt, E., Kitagawa, K., Sondheimer, N., Lindquist, S., Kramer, J.M. and Morimoto, R.I. (2000) Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA, 97, 5750-5755.
53. Miguel-Aliaga, I., Culetto, E., Walker, D.S., Baylis, H.A., Sattelle, D.B., and Davies, K.E. (1999) The Caenorhabditis elegans orthologue of the human gene responsible for spinal muscular atrophy is a maternal product critical for germline maturation and embryonic viability. Hum. Mol. Genet., 8, 2133-2143.
54. Marsh, J.L., Walker, H., Theisen, H., Zhu, Y.Z., Fielder, T., Purcell, J. and Thompson, L.M. (2000) Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet., 9, 13-25.
55. Chan, Y.B., Miguel-Aliaga, I., Franks, C., Thomas, N., Trulzsch, B., Sattelle, D.B., Davies, K.E. and van den Heuvel, M. (2003) Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Hum. Mol. Genet., 12, 1367-1376.
56. Elia, A.J., Parkes, T.L., Kirby, K., St George-Hyslop, P., Boulianne, G.L., Phillips, J.P. and Hilliker, A.J. (1999) Expression of human FALS SOD in motorneurons of Drosophila. Free Radic. Biol. Med. 26, 1332-1338.
57. Feany, M.B. and Bender, W.W. (2000) A Drosophila model of Parkinson's disease. Nature, 404, 394-398.
58. Trulzsch, B., Davies, K. and Wood, M. (2004) Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy. Brain Res. Mol. Brain Res., 120, 145-150.
59. Richmond, J.E. and Jorgensen, E.M. (1999) One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction. Nat. Neurosci., 2, 791-797.
60. Kerr, R., Lev-Ram, V., Baird, G., Vincent, P., Tsien, R.Y. and Schafer, W.R. (2000) Optical imaging of calcium transients in neurons and pharyngeal muscle of C. elegans. Neuron, 26, 583-594.
61. Christensen, M., Estevez, A., Yin, X., Fox, R., Morrison, R., McDonnell, M., Gleason, C., Miller, D.M. III and Strange, K. (2002) A primary culture system for functional analysis of C. elegans neurons and muscle cells. Neuron, 33, 503-514.
62. Kennerdell, J.R. and Carthew, R.W. (2000) Heritable gene silencing in Drosophila using double-stranded RNA. Nat. Biotechnol. 18, 896-898.
63. Dzitoyeva, S., Dimitrijevic, N. and Manev, H. (2001) Intra-abdominal injection of double-stranded RNA into anesthetized adult Drosophila triggers RNA interference in the central nervous system. Mol. Psychiatry, 6, 665-670.
64. Towers, P.R. and Sattelle, D.B. (2002) A Drosophila melanogaster cell line (S2) facilitates post-genome functional analysis of receptors and ion channels. Bioessays, 24, 1066-1073.
65. Cordova, D., Delpech, V.R., Sattelle, D.B. and Rauh, J.J. (2003) Spatiotemporal calcium signaling in a Drosophila melanogaster cell line stably expressing a Drosophila muscarinic acetylcholine receptor. Invert. Neurosci., 5, 19-28.
66. Raymond-Delpech, V., Towers, P.R. and Sattelle, D.B. (2004) Gene silencing of selected calcium-signalling molecules in a Drosophila cell line using double-stranded RNA interference. Cell Calcium, 35, 131-139.
67. Clemens, J.C., Worby, C.A., Simonson-Leff, N., Muda, M., Maehama, T., Hemmings, B.A. and Dixon, J.E. (2000) Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc. Natl Acad. Sci. USA, 97, 6499-6503.
68. Lundgren, J., Masson, P., Realini, C.A. and Young, P. (2003) Use of RNA interference and complementation to study the function of the Drosophila and human 26S proteasome subunit S13. Mol. Cell. Biol., 23, 5320-5330.
69. Cong, F., Schweizer, L., Chamorro, M. and Varmus, H. (2003) Requirement for a nuclear function of β-catenin in Wnt signaling. Mol. Cell. Biol., 23, 8462-8470.
70. Paddison, P.J., Caudy, A.A., Bernstein, E., Hannon, G.J. and Conklin, D.S. (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev., 16, 948-958.
71. Brummelkamp, T.R., Bernards, R. and Agami, R. (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell., 2, 243-247.
72. Carmell, M.A., Zhang, L., Conklin, D.S., Hannon, G.J. and Rosenquist, T.A. (2003) Germline transmission of RNAi in mice. Nat. Struct. Biol., 10, 91-92.
73. Lee, S.S., Lee, R.Y., Fraser, A.G., Kamath, R.S., Ahringer, J. and Ruvkun, G. (2003) A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat. Genet., 33, 40-48.
74. Keating, C.D., Kriek, N., Daniels, M., Ashcroft, N.R., Hopper, N.A., Siney, E.J., Holden-Dye, L. and Burke, J.F. (2003) Whole-genome analysis of 60 G protein-coupled receptors in Caenorhabditis elegans by gene knockout with RNAi. Curr. Biol., 13, 1715-1720.
75. Le Bot, N., Tsai, M.C., Andrews, R.K. and Ahringer, J. (2003) TAC-1, a regulator of microtubule length in the C. elegans embryo. Curr. Biol., 13, 1499-1505.
76. Zipperlen, P., Fraser, A.G., Kamath, R.S., Martinez-Campos, M., and Ahringer, J. (2001) Roles for 147 embryonic lethal genes on C. elegans chromosome I identified by RNA interference and video microscopy. EMBO J., 20, 3984-3992.
77. Nollen, E.A., Garcia, S.M., van Haaften, G., Kim, S., Chavez, A., Morimoto, R.I. and Plasterk, R.H. (2004) Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc. Natl Acad. Sci. USA, 101, 6403-6408.
78. Lum, L., Yao, S., Mozer, B., Rovescalli, A., Von Kessler, D., Nirenberg, M. and Beachy, P.A. (2003) Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science, 299 2039-2045.
79. Berns, K., Hijmans, E.M., Mullenders, J., Brummelkamp, T.R., Velds, A., Heimerikx, M., Kerkhoven, R.M., Madiredjo, M., Nijkamp, W., Weigelt, B. et al. (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature, 428, 431-437.
80. Paddison, P.J., Silva, J.M., Conklin, D.S., Schlabach, M., Li, M., Aruleba, S., Balija, V., O'Shaughnessy, A., Gnoj, L., Scobie, K., Chang, K., Westbrook, T., Cleary, M., Sachidanandam, R., McCombie, W.R., Elledge, S.J., and Hannon, G.J. (2004). A resource for large-scale RNA-interference-based screens in mammals. Nature, 428, 427-431.
81. Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D.N., and Fesik, S.W. (2003) Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl Acad. Sci. USA, 100, 6347-6352.
82. Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G. and Linsley, P.S. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol., 21, 635-637.
83. Shirane, D., Sugao, K., Namiki, S., Tanabe, M., Iino, M. and Hirose, K. (2004) Enzymatic production of RNAi libraries from cDNAs. Nat. Genet., 36, 190-196.
84. Eagle, M., Baudouin, S.V., Chandler, C., Giddings, D.R., Bullock, R. and Bushby, K. (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul. Disord., 12, 926-929.
85. Grisoni, K., Martin, E., Gieseler, K., Mariol, M.C. and Segalat, L. (2002) Genetic evidence for a dystrophin-glycoprotein complex (DGC) in Caenorhabditis elegans. Gene, 294, 77-86.
86. Goldman, R.D., Gruenbaum, Y., Moir, R.D., Shumaker, D.K. and Spann, T.P. (2002) Nuclear lamins: building blocks of nuclear architecture. Genes Dev. Biol., 16, 533-547.
87. Gruenbaum, Y., Lee, K.K., Liu, J., Cohen, M. and Wilson, K.L. (2002) The expression, lamin-dependent localization and RNAi depletion phenotype for emerin in C. elegans. J. Cell Sci., 115, 923-929.
88. Liu, J., Lee, K.K., Segura-Totten, M., Neufeld, E., Wilson, K.L. and Gruenbaum, Y. (2003) MAN1 and emerin have overlapping function(s) essential for chromosome segregation and cell division in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA, 100, 4598-4603.
89. Ilangovan, R., Marshall, W.L., Hua, Y. and Zhou, J. (2003) Inhibition of apoptosis by Z-VAD-fmk in SMN-depleted S2 cells. J. Biol. Chem., 278, 30993-30999.
90. Hsieh-Li, H.M., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai, C.H. and Li, H. (2000) A mouse model for spinal muscular atrophy. Nat. Genet., 24, 66-70.
91. Monani, U.R., Sendtner, M., Coovert, D.D., Parsons, D.W., Andreassi, C., Le, T.T., Jablonka, S., Schrank, B., Rossol, W., Prior, T.W. et al. (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet., 9, 333-339.
92. Candy, A.A., Myers, M., Hannon, G.J. and Hammond, S.M. (2002) Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev., 16, 2491-2496.
93. Carthew, R.W. (2002) RNA interference: the fragile X syndrome connection. Curr. Biol., 12, R852-R854.
94. Gu, Y. and Nelson, D.L. (2003) FMR2 function: insight from a mouse knockout model. Cytogenet. Genome Res., 100, 129-139.
95. Shtang, S., Perry, M.D. and Percy, M.E. (1999) Search for a Caenorhabditis elegans FMR1 homologue: identification of a new putative RNA-binding protein (PRP-1) that hybridizes to the mouse FMR1 double K homology domain. Am. J. Med. Genet., 84, 283-285.
96. Wan, L., Dockendorff, T.C., Jongens, T.A. and Dreyfuss, G. (2000) Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol. Cell. Biol., 20, 8536-8547.
97. Ishizuka, A., Siomi, M.C. and Siomi, H. (2002) A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev., 16, 2497-2508.
98. Link, C.D., Taft, A., Kapulkin, V., Duke, K., Kim, S., Fei, Q., Wood, D.E. and Sahagan, B.G. (2003) Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol. Aging, 24, 397-413.
99. Yagi, Y., Tomita, S., Nakamura, M., and Suzuki, T. (2000) Overexpression of human amyloid precursor protein in Drosophila. Mol. Cell Biol. Res. Commun., 4, 43-49.
100. Iijima, K., Liu, H.-P., Chiang, A.-S., Hearn, S.A., Konsolaki, M. and Zhong, Y. (2004) Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: a potential model for Alzheimer's disease. Proc. Natl Acad. Sci. USA, 101, 6623-6628.
101. Greeve, I., Kretzschmar, D., Tschape, J.A., Beyn, A., Brellinger, C., Schweizer, M., Nitsch, R.M. and Reifegerste, R. (2004) Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J. Neurosci., 24, 3899-3906.
102. Takasugi, N., Takahashi, Y., Morohashi, Y., Tomita, T. and Iwatsubo, T. (2002) The mechanism of gamma-secretase activities through high molecular weight complex formation of presenilins is conserved in Drosophila melanogaster and mammals. J. Biol. Chem., 277, 50198-50205.
103. Francis, R., McGrath, G., Zhang, J., Ruddy, D.A., Sym, M., Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M.C. et al. (2002) aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell, 3, 85-97.
104. Asai, M., Hattori, C., Szabo, B., Sasagawa, N., Maruyama, K., Tanuma, S. and Ishiura, S. (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase. Biochem. Biophys. Res. Commun., 301 231-235.
105. Kao, S.C., Krichevsky, A.M., Kosik, K.S. and Tsai, L.H. (2004) BACE1 suppression by RNA interference in primary cortical neurons. J. Biol. Chem., 279, 1942-1949.
106. Gusella, J.F., Wexler, N.S., Conneally, P.M., Naylor, S.L., Anderson, M.A., Tanzi, R.E., Watkins, P.C., Ottina, K., Wallace, M.R., Sakaguchi, A.Y. et al. (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature, 306, 234-238.
107. Beal, M.F. and Ferrante, R.J. (2004) Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat. Rev. Neurosci., 5, 373-384.
108. Cummings, C.J. and Zoghbi, H.Y. (2000) Fourteen and counting: unraveling trinucleotide repeat diseases. Hum. Mol. Genet., 9 909-916.
109. Lieberman, A.P. and Fischbeck, K.H. (2000) Triplet repeat expansion in neuromuscular disease. Muscle Nerve, 23, 843-850.
110. Caplen, N.J., Taylor, J.P., Statham, V.S., Tanaka, F., Fire, A. and Morgan, R.A. (2002) Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum. Mol. Genet., 11, 175-184.
111. Yang, Y., Nishimura, I., Imai, Y., Takahashi, R. and Lu, B. (2003) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron, 37, 911-924.
112. Hommel, J.D., Sears, R.M., Georgescu, D., Simmons, D.L. and DiLeone, R.J. (2003) Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med., 9, 1539-1544.
113. Bai, J., Ramos, R.L., Ackman, J.B., Thomas, A.M., Lee, R.V. and LoTurco, J.J. (2003) RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat. Neurosci., 6, 1277-1283.
114. Larsson, A. and Engel, J.A. (2004) Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci. Biobehav. Rev., 27, 713-720.
115. Dzitoyeva, S., Dimitrijevic, N. and Manev, H. (2003) Gamma-aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: adult RNA interference and pharmacological evidence. Proc. Natl Acad. Sci. USA, 100, 5485-5490.
116. Gottschalk, P.C., Jacobsen, L.K., and Kosten, T.R. (1999) Current concepts in pharmacotherapy of substance abuse. Curr. Psychiatr. Rep., 1, 172-178.
117. Waggoner, L.E., Dickinson, K.A., Poole, D.S., Tabuse, Y., Miwa, J. and Schafer, W.R. (2000) Long-term nicotine adaptation in Caenorhabditis elegans involves PKC-dependent changes in nicotinic receptor abundance. J. Neurosci., 20, 8802-8811.
118. McCaffrey, A.P., Nakai, H., Pandey, K., Huang, Z., Salazar, F.H., Xu, H., Wieland, S.F., Marion, P.L. and Kay, M.A. (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol., 21, 639-644.
119. Giladi, H., Ketzinel-Gilad, M., Rivkin, L., Felig, Y., Nussbaum, O. and Galun, E. (2003) Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther., 8, 769-776.
120. Song, E., Lee, S.K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P. and Lieberman, J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med., 9, 347-351.
121. Zhang, Y., Boado, R.J. and Pardridge, W.M. (2003) In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J. Gene Med., 5, 1039-1045.
122. Melendez, A., Talloczy, Z., Seaman, M., Eskelinen, E.L., Hall, D.H. and Levine, B. (2003) Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science, 301 1387-1391.
123. Mohmmed, A., Dasaradhi, P.V., Bhatnagar, R.K., Chauhan, V.S. and Malhotra, P. (2003) In vivo gene silencing in Plasmodium berghei - a mouse malaria model. Biochem Biophys. Res. Commun., 309, 506-511.
124. Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W.S. and Khvorova, A. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol., 1, 1.
125. Zhang, L., Yang, N., Mohamed-Hadley, A., Rubin, S.C. and Coukos, G. (2003) Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem. Biophys. Res. Commun., 303, 1169-1178.
126. Miyagishi, M. and Taira, K. (2002) Development and application of siRNA expression vector. Nucl. Acids Res., 2 (suppl.), 113-114.
127. Miyagishi, M. and Taira, K. (2002) U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol., 20, 497-500.
128. Sui, G., Soohoo, C., Affar el, B., Gay, F., Shi, Y. and Forrester, W.C. (2002) A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA, 99, 5515-5520.
129. Yu, J.Y., Taylor, J., DeRuiter, S.L., Vojtek, A.B. and Turner, D.L. (2003) Simultaneous inhibition of GSK3α and GSK3beta using hairpin siRNA expression vectors. Mol. Ther., 7, 228-236.
130. Paul, C.P., Good, P.D., Winer, I. and Engelke, D.R. (2002) Effective expression of small interfering RNA in human cells. Nat. Biotechnol., 20, 505-508.
131. Lee, N.S., Dohjima, T., Bauer, G., Li, H., Li, M.J., Ehsani, A., Salvaterra, P. and Rossi, J. (2002) Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol., 20, 500-505.
132. Hasuwa, H., Kaseda, K., Einarsdottir, T. and Okabe, M. (2002) Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett., 532, 227-230.
133. Van den Haute, C., Eggermont, K., Nuttin, B., Debyser, Z. and Baekelandt, V. (2003) Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum. Gene Ther., 14, 1799-1807.
134. Scherr, M., Battmer, K., Ganser, A. and Eder, M. (2003) Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA. Cell Cycle, 2, 251-257.
135. Rubinson, D.A., Dillon, C.P., Kwiatkowski, A.V., Sievers, C., Yang, L., Kopinja, J., Rooney, D.L., Ihrig, M.M., McManus, M.T., Gertler, F.B. et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet., 33, 401-406.
136. Stewart, S.A., Dykxhoorn, D.M., Palliser, D., Mizuno, H., Yu, E.Y., An, D.S., Sabatini, D.M., Chen, I.S., Hahn, W.C., Sharp, P.A. et al. (2003) Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA, 9, 493-501.
137. Paddison, P.J., Caudy, A.A. and Hannon, G.J. (2002) Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl Acad. Sci. USA, 99, 1443-1448.
138. Xia, H., Mao, Q., Paulson, H.L. and Davidson, B.L. (2002) siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol., 20, 1006-1010.
139. Elbashir, S.M., Martinez, J., Patkaniowska, A., Lendeckel, W. and Tuschl, T. (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888.
140. Kumar, R., Conklin, D.S. and Mittal, V. (2003) High-throughput selection of effective RNAi probes for gene silencing. Genome Res., 13, 2333-2340.
141. Gou, D., Jin, N. and Liu, L. (2003) Gene silencing in mammalian cells by PCR-based short hairpin RNA. FEBS Lett., 548 113-118.
142. Timmons, L., Court, D.L. and Fire, A. (2001) Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene, 263, 103-112.
143. Johnson, N.M., Behm, C.A. and Trowell, S.C. (2003) Wormgate: a high-throughput cloning system for heritable and inducible RNA interference in C. elegans. FASEB 4th Biennial C. elegans Conference.
144. Praitis, V., Casey, E., Collar, D. and Austin, J. (2001) Creation of low-copy integrated transgenic lines in Caenorhabditis elegans. Genetics, 157, 1217-1226.
145. Krichevsky, A.M. and Kosik, K.S. (2002) RNAi functions in cultured mammalian neurons. Proc. Natl Acad. Sci. USA, 99, 11926-11929.
146. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M. et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80, 155-165.
147. Schrank, B., Gotz, R., Gunnersen, J.M., Ure, J.M., Toyka, K.V., Smith, A.G. and Sendtner, M. (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl Acad. Sci. USA, 94, 9920-9925.
148. Stein, P., Svoboda, P., Anger, M. and Schultz, R.M. (2003) RNAi: mammalian oocytes do it without RNA-dependent RNA polymerase. RNA, 9, 187-192.
149. Stein, P., Svoboda, P. and Schultz, R.M. (2003) Transgenic RNAi in mouse oocytes: a simple and fast approach to study gene function. Dev. Biol., 256, 187-193.
150. Czauderna, F., Santel, A., Hinz, M., Fechtner, M., Durieux, B., Fisch, G., Leenders, F., Arnold, W., Giese, K., Klippel, A. et al. (2003) Inducible shRNA expression for application in a prostate cancer mouse model. Nucl. Acids Res., 31, e127.
151. Sarkar, S.N. and Das, H.K. (2003) Regulatory roles of presenilin-1 and nicastrin in neuronal differentiation during in vitro neurogenesis. J. Neurochem., 87, 333-343.
152. Allikian, M.J., Deckert-Cruz, D., Rose, M.R., Landis, G.N. and Tower, J. (2002) Doxycycline-induced expression of sense and inverted-repeat constructs modulates phosphogluconate mutase (Pgm) gene expression in adult Drosophila melanogaster. Genome Biol., 3, 15.
153. Czauderna, F., Fechtner, M., Aygun, H., Arnold, W., Klippel, A., Giese, K. and Kaufmann, J. (2003) Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA. Nucl. Acids Res., 31, 670-682.
154. Wu, RZ, Bailey, S.N. and Sabatini, D.M. (2002) Cell-biological applications of transfected-cell microarrays. Trends Cell Biol., 12, 485-488.
155. Simeoni, F., Morris, M.C., Heitz, F. and Divita, G. (2003) Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucl. Acids Res., 31, 2717-2724.
156. Davidson, B.L. and Paulson, H.L. (2004) Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet Neurol., 3, 145-149.
157. Anders, K.R., Grimson, A. and Anderson, P. (2003) SMG-5, required for C. elegans nonsense-mediated mRNA decay, associates with SMG-2 and protein phosphatase 2A. EMBO J., 22, 641-650.
158. Tomari, Y., Do, T. Haley, B., Schwarz, D.S., Bennett, R., Cook, H.A., Koppetsch, B.S., Theurkauf, W.E. and Zamore, P.D. (2004) RISC assembly defects in the Drosophila RNAi mutant armitage. Cell, 116, 831-841.
159. Domeier, M.E., Morse, D.P., Knight, S.W., Portereiko, M., Bass, B.L. and Mango, S.E. (2000) A link between RNA interference and nonsense-mediated decay in Caenorhabditis elegans. Science, 289 1928-1930.
160. Williams, R.W. and Rubin, G.M. (2002) ARGONAUTE1 is required for efficient RNA interference in Drosophila embryos. Proc. Natl Acad. Sci. USA, 99, 6889-6894.
161. Xia, H., Mao, Q., Eliason, S.L., Harper, S.Q., Martins, I.H., Orr, H.T., Paulson, H.L., Yang, L., Katin, R.M. and Davidson, B.L. (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med., 10, 816-820.